UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 754

Sortiert nach

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

The New England journal of medicine, 2020-01, Vol.382 (3), p.211-221

2020

Volltextzugriff (PDF)

Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study

European journal of clinical investigation, 2019-04, Vol.49 (4), p.e13076-n/a

2019

Volltextzugriff (PDF)

Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta‐analysis

International journal of rheumatic diseases, 2018-03, Vol.21 (3), p.664-672

2018

Volltextzugriff (PDF)

Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality

Arthritis care & research (2010), 2012-02, Vol.64 (2), p.159-168

2012

Volltextzugriff (PDF)

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

Health economics, 2010-04, Vol.19 (4), p.422-437

2010

Volltextzugriff (PDF)

MiR‐146a levels in rheumatoid arthritis and their correlation with disease activity: a meta‐analysis

International journal of rheumatic diseases, 2018-07, Vol.21 (7), p.1335-1342

2018

Volltextzugriff (PDF)

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

Arthritis research & therapy, 2018-06, Vol.20 (1), p.115-115, Article 115

2018

Volltextzugriff (PDF)

Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2024-06, Vol.76 (6), p.823-835

2024

Volltextzugriff (PDF)

Update on the genetic architecture of rheumatoid arthritis

Nature reviews. Rheumatology, 2017-01, Vol.13 (1), p.13

2017

Volltextzugriff (PDF)

Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk

Arthritis research & therapy, 2020-04, Vol.22 (1), p.93-93, Article 93

2020

Volltextzugriff (PDF)

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis

Nature genetics, 2012-03, Vol.44 (3), p.291-296

2012

Volltextzugriff (PDF)

Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2023-09, Vol.75 (9), p.1566-1572

2023

Volltextzugriff (PDF)

Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis

Zeitschrift für Rheumatologie, 2018-04, Vol.77 (3), p.240-248

2018

Volltextzugriff (PDF)

Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis

Arthritis & rheumatology (Hoboken, N.J.), 2021-12, Vol.73 (12), p.2303-2313

2021

Volltextzugriff (PDF)

Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis

Archives of medical research, 2012-07, Vol.43 (5), p.356-362

2012

Volltextzugriff (PDF)

Understanding HLA associations from SNP summary association statistics

Scientific reports, 2019-02, Vol.9 (1), p.1337-1337, Article 1337

2019

Volltextzugriff (PDF)

Distinct transcriptome architectures underlying lupus establishment and exacerbation

Cell, 2022-09, Vol.185 (18), p.3375-3389.e21

2022

Volltextzugriff (PDF)

Allele‐Specific Quantification of HLA–DRB1 Transcripts Reveals Imbalanced Allelic Expression That Modifies the Amino Acid Effects in HLA–DRβ1

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.381-391

2021

Volltextzugriff (PDF)

Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development

Cell transplantation, 2016-01, Vol.25 (1), p.1-15

2016

Volltextzugriff (PDF)

Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study

Arthritis care & research (2010), 2022-12, Vol.74 (12), p.2033-2041

2022

Volltextzugriff (PDF)

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials

International journal of rheumatic diseases, 2016-11, Vol.19 (11), p.1103-1111

2016

Volltextzugriff (PDF)

Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs

International journal of rheumatic diseases, 2013-10, Vol.16 (5), p.527-531

2013

Volltextzugriff (PDF)

Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations

Human molecular genetics, 2014-12, Vol.23 (25), p.6916-6926

2014

Volltextzugriff (PDF)

Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

Arthritis & rheumatology (Hoboken, N.J.), 2023-12, Vol.75 (12), p.2195-2206

2023

Volltextzugriff (PDF)

Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study

Arthritis & rheumatology (Hoboken, N.J.), 2023-03, Vol.75 (3), p.401-410

2023

Volltextzugriff (PDF)

1 – 25 von 754

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(682)
Mit Volltextzugriff
(664)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study

Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta‐analysis

Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

MiR‐146a levels in rheumatoid arthritis and their correlation with disease activity: a meta‐analysis

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus

Update on the genetic architecture of rheumatoid arthritis

Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis

Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus

Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis

Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis

Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis

Understanding HLA associations from SNP summary association statistics

Distinct transcriptome architectures underlying lupus establishment and exacerbation

Allele‐Specific Quantification of HLA–DRB1 Transcripts Reveals Imbalanced Allelic Expression That Modifies the Amino Acid Effects in HLA–DRβ1

Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development

Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials

Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs

Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations

Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study

Suchergebnisse filtern